Chris Richard

Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.

Functions as a College/University

Merlin Nexus invests in both private and public life sciences companies across the globe. The firm focuses on sectors such as biotechnology, medical devices, molecular diagnostics, and specialty pharmaceuticals. It participates in late-stage and PIPE (Private Investments in Public Equity) transactions.

Provides pharmaceutical research

Functions as a College/University

Monashee seeks to provide consistently stronger returns than the broader equity markets by investing systematically in the equity and convertible debt securities of companies raising new equity capital globally or via secondary offerings, block trades, registered direct offerings and PIPEs where a significant shareholder seeks to sell a secondary position. The firm will seek to capture the discount inherent in equity new issues, including both offerings by companies that are already publicly traded (follow-ons) and initial public offerings (IPOs).

Develops clinical-stage immuno-oncology therapeutics

Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer

Operates as a digital asset treasury company